A randomized trial to evaluate the efficacy & safety of Pemetrexed and Platinum Vs Gefitinib in Non-Small Cell Lung Cancer patients

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Oct 2017 Details of Qtwist (quality-adjusted time without symptom or toxicity) analysis method comparing the benefit of gefitinib versus pemetrexed platinum for this trial, presented at the 18th World Conference on Lung Cancer.
06 Sep 2016 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com